CymaBay Therapeutics, Inc.

Report date
12/31/2023
Quarter
2023 Q4
Filed
2/14/2024
Shares
2,573,700
Value ($000)
60,791
Weight
0.2%
2020 Q2 - 2023 Q4 (6 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).